# MnB rLP2086 subfamily B protein

NDC: 68594-028
Generic name: MnB rLP2086 subfamily B protein
Labeler / Manufacturer: Boehringer Ingelheim RCV GmbH & Co KG
Product type: VACCINE
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: SUSPENSION
Routes: —
Marketing started: 20141029



## Active ingredients

- NEISSERIA MENINGITIDIS SEROGROUP B RECOMBINANT LP2086 B01 PROTEIN VARIANT ANTIGEN: .06 mg/.06mg

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68594-028"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68594-028